RTW Biotech Opportunities Ltd
RTWFF
$1.30
-$0.03-2.26%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 5.16M | 4.66M | 4.17M | 3.76M | 3.36M |
| Total Revenue | 5.16M | 4.66M | 4.17M | 3.76M | 3.36M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 5.16M | 4.66M | 4.17M | 3.76M | 3.36M |
| SG&A Expenses | 7.69M | 6.95M | 6.21M | 6.08M | 5.96M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 1.11M | 897.80K | 687.80K | 566.70K | 445.60K |
| Total Operating Expenses | 9.37M | 8.37M | 7.37M | 7.17M | 6.97M |
| Operating Income | -4.21M | -3.71M | -3.20M | -3.41M | -3.62M |
| Income Before Tax | 136.53M | 109.86M | 83.19M | 90.06M | 96.92M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 136.53 | 109.86 | 83.19 | 90.06 | 96.92 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 136.53M | 109.86M | 83.19M | 90.06M | 96.92M |
| EBIT | -4.21M | -3.71M | -3.20M | -3.41M | -3.62M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.50 | 0.45 | 0.39 | 0.43 | 0.46 |
| Normalized Basic EPS | 0.09 | 0.02 | -0.05 | -0.04 | -0.03 |
| EPS Diluted | 0.50 | 0.45 | 0.39 | 0.43 | 0.46 |
| Normalized Diluted EPS | 0.09 | 0.02 | -0.05 | -0.04 | -0.03 |
| Average Basic Shares Outstanding | 1.09B | 969.37M | 846.05M | 847.80M | 849.56M |
| Average Diluted Shares Outstanding | 1.09B | 969.37M | 846.05M | 847.80M | 849.56M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
